Literature DB >> 10158268

The willingness to pay for health changes, the human-capital approach and the external costs.

M Johannesson1.   

Abstract

In this paper, the relationship between willingness to pay for health changes, the human-capital approach, and the costs that should be included in a cost-benefit analysis of a health care programme are analysed. The costs that should be included are defined as the change in consumption minus the change in production of the individual that receives a health care programme. The size of these external costs differs depending on the institutional arrangements in society. It is shown that the net production version of the human-capital approach is an estimation of the external costs. The human-capital approach can thus be given a theoretical foundation in cost-benefit analysis if it is used to estimate the external costs.

Entities:  

Mesh:

Year:  1996        PMID: 10158268     DOI: 10.1016/0168-8510(96)00815-9

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  21 in total

Review 1.  A review of health-related workplace productivity loss instruments.

Authors:  Jennifer H Lofland; Laura Pizzi; Kevin D Frick
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain's economy?

Authors:  Juan Oliva-Moreno
Journal:  Eur J Health Econ       Date:  2011-08-20

Review 3.  Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence.

Authors:  Kenneth Tang
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

4.  Health-related productivity loss: NICE to recognize soon, good to discuss now.

Authors:  Wei Zhang; Aslam H Anis
Journal:  Pharmacoeconomics       Date:  2014-05       Impact factor: 4.981

Review 5.  Oral serotonin receptor agonists: a review of their cost effectiveness in migraine.

Authors:  Jennifer H Lofland; David B Nash
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  The economic burden of rheumatoid arthritis: beyond health care costs.

Authors:  Wei Zhang; Aslam H Anis
Journal:  Clin Rheumatol       Date:  2011-03-02       Impact factor: 2.980

7.  The annual societal cost of alcohol misuse in Scotland.

Authors:  Susan J Varney; Julian F Guest
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Economic analysis of methamphetamine prevention effects and employer costs.

Authors:  Max Guyll; Richard Spoth; D Max Crowley
Journal:  J Stud Alcohol Drugs       Date:  2011-07       Impact factor: 2.582

9.  Indirect costs in ambulatory patients with HIV/AIDS in Spain: a pilot study.

Authors:  Juan Oliva; César Roa; Juan del Llano
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Health coaching to improve self-care of informal caregivers of adults with chronic heart failure - iCare4Me: Study protocol for a randomized controlled trial.

Authors:  Barbara Riegel; Alexandra L Hanlon; Norma B Coe; Karen B Hirschman; Gladys Thomas; Michael Stawnychy; Joyce W Wald; Kathryn H Bowles
Journal:  Contemp Clin Trials       Date:  2019-09-06       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.